Literature DB >> 35562258

Local Therapies in Advanced Colorectal Cancer.

Kathryn E Hitchcock1, Paul B Romesser2, Eric D Miller3.   

Abstract

Curative intent surgical resection of colorectal metastases to the liver and lungs in eligible patients results in improved disease control and prolonged overall survival with the potential for cure in a subset of patients. Additional ablative and local therapies for use in the liver, lungs, and other body sites have been developed with emerging data on the utility and toxicity of these treatments. Future studies should focus on identification of appropriate candidates for treatment and determining the optimal modality and timing of treatment accounting for both patient and disease factors.
Copyright © 2022 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Ablative therapy; Colorectal cancer; Local therapy; Metastatic; Stereotactic ablative radiotherapy; Surgery

Mesh:

Year:  2022        PMID: 35562258      PMCID: PMC9177055          DOI: 10.1016/j.hoc.2022.02.007

Source DB:  PubMed          Journal:  Hematol Oncol Clin North Am        ISSN: 0889-8588            Impact factor:   2.861


  59 in total

1.  Hepatic Arterial Infusion in Combination with Modern Systemic Chemotherapy is Associated with Improved Survival Compared with Modern Systemic Chemotherapy Alone in Patients with Isolated Unresectable Colorectal Liver Metastases: A Case-Control Study.

Authors:  Mashaal Dhir; Heather L Jones; Yongli Shuai; Amber K Clifford; Samantha Perkins; Jennifer Steve; Melissa E Hogg; M Haroon A Choudry; James F Pingpank; Matthew P Holtzman; Herbert J Zeh; Nathan Bahary; David L Bartlett; Amer H Zureikat
Journal:  Ann Surg Oncol       Date:  2016-07-18       Impact factor: 5.344

2.  Hepatic arterial infusion of chemotherapy after resection of hepatic metastases from colorectal cancer.

Authors:  N Kemeny; Y Huang; A M Cohen; W Shi; J A Conti; M F Brennan; J R Bertino; A D Turnbull; D Sullivan; J Stockman; L H Blumgart; Y Fong
Journal:  N Engl J Med       Date:  1999-12-30       Impact factor: 91.245

3.  Lung metastasectomy after colorectal cancer: prognostic impact of resection margin on long term survival, a retrospective cohort study.

Authors:  Federico Davini; Sara Ricciardi; Carmelina C Zirafa; Gaetano Romano; Greta Alì; Gabriella Fontanini; Franca M A Melfi
Journal:  Int J Colorectal Dis       Date:  2019-11-04       Impact factor: 2.571

4.  The clinical correlation of an autopsy study of recurrent colorectal cancer.

Authors:  J P Welch; G A Donaldson
Journal:  Ann Surg       Date:  1979-04       Impact factor: 12.969

5.  Survival Following Resection of Intra- and Extra-Hepatic Metastases from Colorectal Cancer: A Phase II Trial.

Authors:  Alice C Wei; Natalie G Coburn; Katharine S Devitt; Pablo E Serrano; Carol-Anne Moulton; Sean P Cleary; Calvin Law; Malcolm J Moore; Steven Gallinger
Journal:  Ann Surg Oncol       Date:  2016-03-30       Impact factor: 5.344

6.  Individual data meta-analysis for the study of survival after pulmonary metastasectomy in colorectal cancer patients: A history of resected liver metastases worsens the prognosis.

Authors:  Jon Zabaleta; Tomohiko Iida; Pierre E Falcoz; Samer Salah; José R Jarabo; Arlene M Correa; Maria G Zampino; Takashi Matsui; Sukki Cho; Francesco Ardissone; Kazuhiro Watanabe; Michel Gonzalez; Pascal Gervaz; Jose I Emparanza; Víctor Abraira
Journal:  Eur J Surg Oncol       Date:  2018-03-21       Impact factor: 4.424

7.  Single-Fraction Stereotactic vs Conventional Multifraction Radiotherapy for Pain Relief in Patients With Predominantly Nonspine Bone Metastases: A Randomized Phase 2 Trial.

Authors:  Quynh-Nhu Nguyen; Stephen G Chun; Edward Chow; Ritsuko Komaki; Zhongxing Liao; Rensi Zacharia; Bill K Szeto; James W Welsh; Stephen M Hahn; C David Fuller; Bryan S Moon; Justin E Bird; Robert Satcher; Patrick P Lin; Melenda Jeter; Michael S O'Reilly; Valerae O Lewis
Journal:  JAMA Oncol       Date:  2019-06-01       Impact factor: 31.777

8.  First-line selective internal radiotherapy plus chemotherapy versus chemotherapy alone in patients with liver metastases from colorectal cancer (FOXFIRE, SIRFLOX, and FOXFIRE-Global): a combined analysis of three multicentre, randomised, phase 3 trials.

Authors:  Harpreet S Wasan; Peter Gibbs; Navesh K Sharma; Julien Taieb; Volker Heinemann; Jens Ricke; Marc Peeters; Michael Findlay; Andrew Weaver; Jamie Mills; Charles Wilson; Richard Adams; Anne Francis; Joanna Moschandreas; Pradeep S Virdee; Peter Dutton; Sharon Love; Val Gebski; Alastair Gray; Guy van Hazel; Ricky A Sharma
Journal:  Lancet Oncol       Date:  2017-08-03       Impact factor: 41.316

9.  Local Treatment of Unresectable Colorectal Liver Metastases: Results of a Randomized Phase II Trial.

Authors:  Theo Ruers; Frits Van Coevorden; Cornelis J A Punt; Jean-Pierre E N Pierie; Inne Borel-Rinkes; Jonathan A Ledermann; Graeme Poston; Wolf Bechstein; Marie-Ange Lentz; Murielle Mauer; Gunnar Folprecht; Eric Van Cutsem; Michel Ducreux; Bernard Nordlinger
Journal:  J Natl Cancer Inst       Date:  2017-09-01       Impact factor: 11.816

10.  Ablation or Resection for Colorectal Liver Metastases? A Systematic Review of the Literature.

Authors:  Philipp Kron; Michael Linecker; Robert P Jones; Giles J Toogood; Pierre-Alain Clavien; J P A Lodge
Journal:  Front Oncol       Date:  2019-10-16       Impact factor: 6.244

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.